Skip to main content
Account

Peer review reports

From: Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

Original Submission
27 Oct 2020 Submitted Original manuscript
14 Feb 2021 Reviewed Reviewer Report
26 Feb 2021 Reviewed Reviewer Report
5 May 2021 Author responded Author comments - Chiao-En Wu
Resubmission - Version 2
5 May 2021 Submitted Manuscript version 2
6 May 2021 Reviewed Reviewer Report
29 May 2021 Reviewed Reviewer Report
28 Jun 2021 Author responded Author comments - Chiao-En Wu
Resubmission - Version 3
28 Jun 2021 Submitted Manuscript version 3
Publishing
29 Jun 2021 Editorially accepted
27 Jul 2021 Article published 10.1186/s12885-021-08587-w

Learn about peer review

Back to article page

Navigation